Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Société Générale M&A Activity 2021

May 11, 2021

1671_mrq_2021-05-11_d3ab13f6-6c12-4001-a3f4-0bd715b78725.html

M&A Activity

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 2037Y

Societe Generale SA

11 May 2021

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.       KEY INFORMATION

Name of person dealing (Note 1) Société Générale S.A.
Company dealt in Willis Towers Watson plc
Class of relevant security to which the dealings being disclosed relate (Note 2) US$0.000304635 ordinary shares
Date of dealing 10/05/2021

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long Short
Number (%) Number (%)
(1) Relevant securities 1,319,478 1.02 3,345 0.00
(2) Derivatives (other than options) 1,133 0.00 586,027 0.45
(3) Options and agreements to purchase/sell 0 0.00 0 0.00
Total *1,570,007 *1.22 589,372 0.46

* Include the holding of shares 249,396 on borrow products

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1.       DEALINGS (Note 4)

(a)      Purchases and sales

Purchase/sale Number of relevant securities Price per unit USD (Note 5)
Purchase 1 270.7
Purchase 10 271.72
Purchase 15 269.07
Purchase 11 269.14
Purchase 93 269.57
Purchase 10 271.06
Purchase 11 270.61
Purchase 7 269.57
Purchase 10 270.13
Purchase 523 271.87
Purchase 1,767 268.88
Purchase 1 268.99
Purchase 36 269.1
Purchase 36 269.04
Purchase 5 271.87
Purchase 76 271.87
Purchase 149 271.87
Sale 17 271.87
Sale 89 268.98
Sale 2 271.18
Sale 3 271.18
Sale 12 271.18
Sale 78 271.18
Sale 25 270.73
Sale 75 270.73
Sale 2 271.18
Sale 3 271.18
Sale 100 269.55
Sale 1 269.67
Sale 25 269.67
Sale 47 269.67
Sale 27 269.67
Sale 100 270.99
Sale 4 271.87
Sale 28 268.88
Sale 100 271.02
Sale 4 270.85
Sale 11 270.85
Sale 3 269.62
Sale 20 269.62
Sale 40 269.62
Sale 85 270.85
Sale 6 269.62
Sale 5 269.62
Sale 26 269.62
Sale 100 269.5
Sale 100 270.31
Sale 3 271.2
Sale 97 271.2
Sale 36 269.47
Sale 100 271.1
Sale 20 268.74
Sale 80 268.74
Sale 63 269.47
Sale 1 269.47
Sale 72 271.61
Sale 456 268.88
Total Purchases 2,761
Total Sales 2,066

Derivatives transactions (other than options transactions)

Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit USD

(Note 5)

(b)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii)      Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(c)      Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2.       OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the 

voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition 

or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            No

Date of disclosure 11/05/2021
Contact name Société Générale - Disclosure team
Telephone number +33 1 42 14 92 74
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEDFLBFFELBBBF